News tagged with glaxosmithkline
Related topics: diabetes , heart attack , food and drug administration , vaccine
The pharmaceutical industry's efforts to self-regulate its direct-to-consumer (DTC) advertising are "an industry-sponsored ruse," intended to deflect criticism and collectively block new Federal regulation, a study released ...
Health Feb 15, 2013 | 5 / 5 (1) | 0
An increasing number of bacteria is evolving antibiotic resistance. Much-feared representatives of this steadily growing group include Staphylococci strains. At this point, multi-resistant forms of the ba ...
Diseases, Conditions, Syndromes Feb 13, 2013 | not rated yet | 0
British drugs firm GlaxoSmithKline on Wednesday unveiled a 13-percent drop in annual net profits and outlined a plan for more restructuring in Europe to deliver greater savings and offset weaker sales across the region.
Other Feb 06, 2013 | not rated yet | 0
A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This ...
Alzheimer's disease & dementia Jan 15, 2013 | 5 / 5 (4) | 0
Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax.
Medications Dec 14, 2012 | not rated yet | 0
British drugmaker GlaxoSmithKline said it intends to increase its holdings in its Indian and Nigerian divisions, as part of a long-term strategy to expand into emerging markets, in a statement on Monday.
Other Nov 26, 2012 | not rated yet | 0
The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.
Medications Nov 25, 2012 | not rated yet | 0
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Other Nov 01, 2012 | not rated yet | 0
(Medical Xpress)—A new study from the University of Alberta shows that your genes could be the reason your allergic asthma or hay fever is so severe.
Inflammatory disorders Oct 15, 2012 | 5 / 5 (1) | 0
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Cancer Oct 08, 2012 | not rated yet | 0 |
(HealthDay)—Among people at high risk for cardiovascular disease, knowing their blood levels of two specific markers for inflammation might help prevent a heart attack or stroke, according to British investigators.
Cardiology Oct 04, 2012 | 4 / 5 (2) | 0 |
(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.
Medications Oct 03, 2012 | 5 / 5 (1) | 0
Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma. The results of a ...
Cancer Sep 29, 2012 | not rated yet | 0
(AP)—A consumer advocacy group is reporting that pharmaceutical companies have paid more than $30 billion to state and federal governments to settle allegations of fraud over the last 20 years.
Medications Sep 27, 2012 | not rated yet | 0
A swine flu vaccine used in 2009-10 is linked to a higher risk of the sleeping disorder narcolepsy in children and teens in Sweden and Finland, the European Centre for Disease Prevention and Control said Friday.
Medications Sep 21, 2012 | 4.7 / 5 (3) | 0